A Comparison of the Roles of Peroxisome Proliferator-Activated Receptor and Retinoic Acid Receptor on CYP26 RegulationMol. Pharmacol., Feb 2010; 77: 218 - 227
[CYP26B1]
TurboFectin 8.0™ is a new generation of transfection reagent optimized for nucleic acid delivery into eukaryotic cells. Its proprietary formulation of lipid/histone blend is supplied in 80% alcohol. TurboFectin 8.0 is the recommended transfection reagent for delivery of TrueClone/TrueORF Clone (for over-expression) and HuSH-29 constructs (shRNA for expression knock-down) in many established cell lines and cell types.
Superior performance: Comparable with FuGENE®6 in transfection efficiency and low cytotoxicity
Wide spectrum: Over 100 cell lines and primary cell types have been successfully transfected with TurboFectin 8.0
Affordability: cost lower than FuGENE®
Magnetofection™ - A novel and highly efficient method to transfect cells in culture. It exploits magnetic force exerted upon gene vectors associated with magnetic particles to draw the vectors into target cells.
Validated to work in a broad range of cell types, including primary cells and neuronal cells
Greatly improved transfection rates compared to standard transfection
Up to several thousand fold increased levels of transgene expression compared to standard transfections upon short-term incubation
Magnetofection Reagents are only available through OriGene in the US
MegaTran 1.0 is a polymer based transfection reagent specially designed and manufactured for high volume DNA transfection and large scale protein production in HEK293T, CHO and 293S cells.
Superior transfection efficiency and low toxicity
Improved protein production via transient transfection
